Inducare Pharmaceuticals And Research Foundation, a active private not for profit company, was established on 19 February 2019 in Purandar, Maharashtra, India. Engaging in pharma contract r&d within the hospital and medical care sector, it holds CIN: U85300PN2019NPL182301. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹5.31 Cr.
It upholds a compliant status. Its leadership includes Monali Narayanrao Rajurkar (Nominee Director), Vishal Vilas Salunke (Additional Director), Tukaram Sampat Bhondave (Director). Past directors included Sandeep Narayan Gogawale, Monali Narayanrao Rajurkar, Tukaram Sampat Bhondave. It holds ₹15.78 Cr open charges and ₹4.06 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. G-32, Midc Jejuri Area,, Jejuri, Taluka Purandhar, Purandar, Maharashtra, 412303.
U85300PN2019NPL182301
182301
19 February 2019
₹10.00 Cr
₹5.31 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Inducare Pharmaceuticals And Research Foundation — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monali Narayanrao Rajurkar | Nominee Director | 26 Feb 2021 | Current |
| Vishal Vilas Salunke | Additional Director | 19 Jun 2025 | Current |
| Tukaram Sampat Bhondave | Director | 03 Sep 2019 | Current |
| Ramadas Subhash Kute | Director | 19 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Feb 2021 | Past |
| Pramod Abcsdd | Director | 18 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 18 Feb 2021 | Past |
| Pramod Abcsdd | Director | 18 Feb 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inducare Pharmaceuticals And Research Foundation, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 46.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Inducare Pharmaceuticals And Research Foundation had a promoter holding of 61.77% and a public holding of 38.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹157,773,000.00
₹40,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2023 | Others | ₹6.00 Cr | Open |
| 23 Feb 2023 | Others | ₹5.92 Cr | Open |
| 23 Feb 2023 | Others | ₹3.86 Cr | Open |
| 11 Jan 2022 | Others | ₹4.06 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inducare Pharmaceuticals And Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inducare Pharmaceuticals And Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inducare Pharmaceuticals And Research Foundation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vishal Vilas Salunke was appointed as a Additional Director was appointed as a Additional Director on 19 Jun 2025 & has been associated with this company since 5 months 18 days . was completed.
Inducare Pharmaceuticals And Research Foundation last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Inducare Pharmaceuticals And Research Foundation has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100817897 was registered on 01 Nov 2023. was completed.
A charge with Others amounted to Rs. 5.92 Cr with Charge ID 100693916 was registered on 23 Feb 2023. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 3.86 Cr with Charge ID 100693915 was registered on 23 Feb 2023. was completed.
The CIN of Inducare Pharmaceuticals And Research Foundation is U85300PN2019NPL182301.
Inducare Pharmaceuticals And Research Foundation is headquartered at Plot No. G-32, Midc Jejuri Area,, Jejuri, Taluka Purandhar, Purandar, Maharashtra, 412303.
Inducare Pharmaceuticals And Research Foundation was incorporated on 19 February 2019.
The current directors of Inducare Pharmaceuticals And Research Foundation are
The primary industry of Inducare Pharmaceuticals And Research Foundation is Hospital And Medical Care.
Inducare Pharmaceuticals And Research Foundation is unlisted.
The authorized capital of Inducare Pharmaceuticals And Research Foundation is ₹10.00 Cr, and the paid-up capital is ₹5.31 Cr.
The compliance status of Inducare Pharmaceuticals And Research Foundation is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX